Acuta Capital Partners as of Dec. 31, 2018
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 19 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iovance Biotherapeutics (IOVA) | 20.4 | $27M | 3.0M | 8.85 | |
| Assembly Biosciences | 12.4 | $16M | 719k | 22.62 | |
| Kadmon Hldgs | 12.0 | $16M | 7.5M | 2.08 | |
| Immunomedics | 8.7 | $11M | 800k | 14.27 | |
| Biohaven Pharmaceutical Holding | 6.8 | $8.9M | 241k | 36.98 | |
| CAS Medical Systems | 6.4 | $8.4M | 5.3M | 1.60 | |
| SPDR S&P Biotech (XBI) | 5.5 | $7.2M | 100k | 71.75 | |
| Amarin Corporation (AMRN) | 4.5 | $6.0M | 438k | 13.61 | |
| Veracyte (VCYT) | 4.2 | $5.6M | 443k | 12.58 | |
| IRIDEX Corporation (IRIX) | 4.2 | $5.5M | 1.2M | 4.70 | |
| Argenx Se (ARGX) | 3.9 | $5.1M | 53k | 96.08 | |
| Kalvista Pharmaceuticals (KALV) | 2.6 | $3.4M | 173k | 19.75 | |
| Xenon Pharmaceuticals (XENE) | 2.6 | $3.4M | 538k | 6.31 | |
| Acer Therapeutics | 2.2 | $2.9M | 143k | 20.12 | |
| Chembio Diagnostics | 1.7 | $2.2M | 387k | 5.66 | |
| Viewray (VRAYQ) | 1.4 | $1.9M | 312k | 6.07 | |
| Sutro Biopharma (STRO) | 0.3 | $410k | 46k | 9.01 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $202k | 25k | 8.08 | |
| Outlook Therapeutics | 0.0 | $15k | 29k | 0.52 |
